Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 13, 2026 Filed Oct 14, 2026 19:59 UTC |
Subramaniam RajeshDirector
|
GrantCommon Stock | 1,438 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000225 · form4.xml · nonDerivative · entry 1 Subramaniam Rajesh · CIK 0001679607 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,768.4107 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| October 13, 2026 Filed Oct 14, 2026 19:58 UTC |
Portman Robert JonesDirector
|
GrantCommon Stock | 1,438 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000224 · form4.xml · nonDerivative · entry 1 Portman Robert Jones · CIK 0001973769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,684.6454 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Read SEC document |
| October 13, 2026 Filed Oct 14, 2026 19:56 UTC |
McEvoy AshleyDirector
|
GrantCommon Stock | 1,438 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000223 · form4.xml · nonDerivative · entry 1 McEvoy Ashley · CIK 0001745936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,666.0049 F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Read SEC document |
| October 13, 2026 Filed Oct 14, 2026 19:55 UTC |
McCarthy Christine MDirector
|
GrantCommon Stock | 1,438 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000222 · form4.xml · nonDerivative · entry 1 McCarthy Christine M · CIK 0001332169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,341.7543 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Read SEC document |
| October 13, 2026 Filed Oct 14, 2026 19:54 UTC |
Kempczinski Christopher JDirector
|
GrantCommon Stock | 1,438 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000221 · form4.xml · nonDerivative · entry 1 Kempczinski Christopher J · CIK 0001598115 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,371.6723 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Read SEC document |
| October 13, 2026 Filed Oct 14, 2026 19:52 UTC |
JIMENEZ JOSEPHDirector
|
GrantCommon Stock | 1,438 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000220 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,967.634 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Read SEC document |
| October 13, 2026 Filed Oct 14, 2026 19:51 UTC |
Chang AmyDirector
|
GrantCommon Stock | 1,438 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000219 · form4.xml · nonDerivative · entry 1 Chang Amy · CIK 0001551504 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,897.4493 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| October 13, 2026 Filed Oct 14, 2026 19:50 UTC |
Bonini SheilaDirector
|
GrantCommon Stock | 1,438 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000218 · form4.xml · nonDerivative · entry 1 Bonini Sheila · CIK 0001973331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,982.6437 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| October 13, 2026 Filed Oct 14, 2026 19:48 UTC |
Biggs M. BrettDirector
|
GrantCommon Stock | 1,438 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000217 · form4.xml · nonDerivative · entry 1 Biggs M. Brett · CIK 0001662848 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,900.4756 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| October 13, 2026 Filed Oct 14, 2026 19:47 UTC |
ARNOLD CRAIGDirector
|
GrantCommon Stock | 1,438 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000216 · form4.xml · nonDerivative · entry 1 ARNOLD CRAIG · CIK 0001188578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,474.1836 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Read SEC document |
| October 13, 2026 Filed Oct 14, 2026 19:46 UTC |
Allen Bertrand MarcDirector
|
GrantCommon Stock | 1,438 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000215 · form4.xml · nonDerivative · entry 1 Allen Bertrand Marc · CIK 0001632131 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,697.6399 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| October 05, 2026 Filed Oct 6, 2026 20:21 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 3,914 | $145.34 | $568,860.76 |
DisclosureSEC source: 0000080424-26-000200 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,618.0097 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit Award. Read SEC document |
| October 05, 2026 Filed Oct 6, 2026 20:11 UTC |
Gama PaulCEO- Health Care
|
SaleCommon Stock | 2,225 | $145.34 | $323,381.50 |
DisclosureSEC source: 0000080424-26-000199 · form4.xml · nonDerivative · entry 1 Gama Paul · CIK 0002110932 · CEO- Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,123.8803 F1 · shares: Shares sold to cover tax obligation upon settlement of Restricted Stock Unit award. Read SEC document |
| October 05, 2026 Filed Oct 6, 2026 20:00 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
SaleCommon Stock | 2,369 | $145.34 | $344,310.46 |
DisclosureSEC source: 0000080424-26-000198 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,729.9685 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 18:32 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
GrantStock Option (Right to Buy) · Derivative | 24,330 | $0.00 Strike: $143.95 | $0.00 |
DisclosureSEC source: 0000080424-26-000197 · form4.xml · derivative · entry 3 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,330 Underlying: Common Stock · 24,330 shares Expires 2036-10-01 Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 18:32 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
GrantCommon Stock | 6,110 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000197 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,098.9685 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 18:30 UTC |
Schulten AndreChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 78,324 | $0.00 Strike: $143.95 | $0.00 |
DisclosureSEC source: 0000080424-26-000196 · form4.xml · derivative · entry 3 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,324 Underlying: Common Stock · 78,324 shares Expires 2036-10-01 Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 18:30 UTC |
Schulten AndreChief Financial Officer
|
GrantCommon Stock | 6,557 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000196 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,532.0097 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 18:29 UTC |
Gama PaulCEO- Health Care
|
GrantCommon Stock | 12,517 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000195 · form4.xml · nonDerivative · entry 1 Gama Paul · CIK 0002110932 · CEO- Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,348.8803 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 17:55 UTC |
Jejurikar ShaileshDirector · Chairman, President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 191,909 | $0.00 Strike: $143.95 | $0.00 |
DisclosureSEC source: 0000080424-26-000194 · form4.xml · derivative · entry 5 Jejurikar Shailesh · CIK 0001746310 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,909 Underlying: Common Stock · 191,909 shares Expires 2036-10-01 Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 17:55 UTC |
Jejurikar ShaileshDirector · Chairman, President and CEO
|
GrantCommon Stock | 16,065 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000194 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,390.9973 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 17:53 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantStock Option (Right to Buy) · Derivative | 22,822 | $0.00 Strike: $143.95 | $0.00 |
DisclosureSEC source: 0000080424-26-000193 · form4.xml · derivative · entry 4 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,822 Underlying: Common Stock · 22,822 shares Expires 2036-10-01 Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 17:53 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantCommon Stock | 5,732 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000193 · form4.xml · nonDerivative · entry 1 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,243.0935 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 17:52 UTC |
Santos de Azevedo Juliana MonteiroCEO - Grooming
|
GrantStock Option (Right to Buy) · Derivative | 37,382 | $0.00 Strike: $143.95 | $0.00 |
DisclosureSEC source: 0000080424-26-000192 · form4.xml · derivative · entry 4 Santos de Azevedo Juliana Monteiro · CIK 0002132273 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,382 Underlying: Common Stock · 37,382 shares Expires 2036-10-01 Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 17:52 UTC |
Santos de Azevedo Juliana MonteiroCEO - Grooming
|
GrantCommon Stock | 3,130 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000192 · form4.xml · nonDerivative · entry 1 Santos de Azevedo Juliana Monteiro · CIK 0002132273 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,731.2363 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 17:51 UTC |
Bharucha Freddy P.CEO - Beauty
|
GrantStock Option (Right to Buy) · Derivative | 3,126 | $0.00 Strike: $143.95 | $0.00 |
DisclosureSEC source: 0000080424-26-000191 · form4.xml · derivative · entry 7 Bharucha Freddy P. · CIK 0002097043 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 3,126 Underlying: Common Stock · 3,126 shares Expires 2036-10-01 Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 17:51 UTC |
Bharucha Freddy P.CEO - Beauty
|
GrantStock Option (Right to Buy) · Derivative | 49,843 | $0.00 Strike: $143.95 | $0.00 |
DisclosureSEC source: 0000080424-26-000191 · form4.xml · derivative · entry 6 Bharucha Freddy P. · CIK 0002097043 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,843 Underlying: Common Stock · 49,843 shares Expires 2036-10-01 Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 17:49 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 13,648 | $0.00 Strike: $143.95 | $0.00 |
DisclosureSEC source: 0000080424-26-000190 · form4.xml · derivative · entry 3 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,648 Underlying: Common Stock · 13,648 shares Expires 2036-10-01 Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 17:48 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantStock Option (Right to Buy) · Derivative | 44,994 | $0.00 Strike: $143.95 | $0.00 |
DisclosureSEC source: 0000080424-26-000189 · form4.xml · derivative · entry 7 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,994 Underlying: Common Stock · 44,994 shares Expires 2036-10-01 Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 17:44 UTC |
Raman Sundar G.CEO-Fabric Home & Habitat Care
|
GrantStock Option (Right to Buy) · Derivative | 69,780 | $0.00 Strike: $143.95 | $0.00 |
DisclosureSEC source: 0000080424-26-000188 · form4.xml · derivative · entry 3 Raman Sundar G. · CIK 0001882672 · CEO-Fabric Home & Habitat Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,780 Underlying: Common Stock · 69,780 shares Expires 2036-10-01 Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 17:43 UTC |
Purushothaman BalajiChief Human Resources Officer
|
GrantStock Option (Right to Buy) · Derivative | 39,160 | $0.00 Strike: $143.95 | $0.00 |
DisclosureSEC source: 0000080424-26-000187 · form4.xml · derivative · entry 3 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,160 Underlying: Common Stock · 39,160 shares Expires 2036-10-01 Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 17:42 UTC |
Abd El Hak HeshamCEO-Baby and Feminine Care
|
GrantStock Option (Right to Buy) · Derivative | 41,536 | $0.00 Strike: $143.95 | $0.00 |
DisclosureSEC source: 0000080424-26-000186 · form4.xml · derivative · entry 4 Abd El Hak Hesham · CIK 0002134647 · CEO-Baby and Feminine Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,536 Underlying: Common Stock · 41,536 shares Expires 2036-10-01 Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 17:46 UTC |
Bharucha Freddy P.CEO - Beauty
|
GrantStock Option (Right to Buy) · Derivative | 9,271 | $0.00 Strike: $146.67 | $0.00 |
DisclosureSEC source: 0000080424-26-000171 · form4.xml · derivative · entry 6 Bharucha Freddy P. · CIK 0002097043 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,271 Underlying: Common Stock · 9,271 shares Expires 2036-09-15 Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 17:45 UTC |
Purushothaman BalajiChief Human Resources Officer
|
GrantStock Option (Right to Buy) · Derivative | 12,336 | $0.00 Strike: $146.67 | $0.00 |
DisclosureSEC source: 0000080424-26-000170 · form4.xml · derivative · entry 3 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,336 Underlying: Common Stock · 12,336 shares Expires 2036-09-15 Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 17:43 UTC |
Jejurikar ShaileshDirector · Chairman, President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 22,787 | $0.00 Strike: $146.67 | $0.00 |
DisclosureSEC source: 0000080424-26-000169 · form4.xml · derivative · entry 5 Jejurikar Shailesh · CIK 0001746310 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,787 Underlying: Common Stock · 22,787 shares Expires 2036-09-15 Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 17:42 UTC |
Santos de Azevedo Juliana MonteiroCEO - Grooming
|
GrantStock Option (Right to Buy) · Derivative | 14,476 | $0.00 Strike: $146.67 | $0.00 |
DisclosureSEC source: 0000080424-26-000168 · form4.xml · derivative · entry 4 Santos de Azevedo Juliana Monteiro · CIK 0002132273 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,476 Underlying: Common Stock · 14,476 shares Expires 2036-09-15 Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 17:41 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantStock Option (Right to Buy) · Derivative | 3,519 | $0.00 Strike: $146.67 | $0.00 |
DisclosureSEC source: 0000080424-26-000167 · form4.xml · derivative · entry 4 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,519 Underlying: Common Stock · 3,519 shares Expires 2036-09-15 Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 18:36 UTC |
Portman Robert JonesDirector
|
GrantCommon Stock | 52 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000166 · form4.xml · nonDerivative · entry 1 Portman Robert Jones · CIK 0001973769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,246.6454 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 18:34 UTC |
McEvoy AshleyDirector
|
GrantCommon Stock | 207 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000165 · form4.xml · nonDerivative · entry 1 McEvoy Ashley · CIK 0001745936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,228.0049 F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 18:33 UTC |
McCarthy Christine MDirector
|
GrantCommon Stock | 258 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000164 · form4.xml · nonDerivative · entry 1 McCarthy Christine M · CIK 0001332169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,903.7543 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 18:32 UTC |
Kempczinski Christopher JDirector
|
GrantCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000163 · form4.xml · nonDerivative · entry 1 Kempczinski Christopher J · CIK 0001598115 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,933.6723 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 18:30 UTC |
JIMENEZ JOSEPHDirector
|
GrantCommon Stock | 327 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000162 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,529.634 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 18:28 UTC |
ARNOLD CRAIGDirector
|
GrantCommon Stock | 207 | $0.00 | $0.00 |
DisclosureSEC source: 0000080424-26-000161 · form4.xml · nonDerivative · entry 1 ARNOLD CRAIG · CIK 0001188578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,036.1836 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| August 24, 2026 Filed Aug 24, 2026 20:34 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
SaleCommon Stock | 359 | $145.24 | $52,141.16 |
DisclosureSEC source: 0000080424-26-000159 · form4.xml · nonDerivative · entry 1 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,271.2791 Read SEC document |
| August 21, 2026 Filed Aug 24, 2026 19:47 UTC |
Raman Sundar G.CEO-Fabric Home & Habitat Care
|
SaleCommon Stock | 3,435 | $143.02 | $491,273.70 |
DisclosureSEC source: 0000080424-26-000156 · form4.xml · nonDerivative · entry 1 Raman Sundar G. · CIK 0001882672 · CEO-Fabric Home & Habitat Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,744.8463 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 16:40 UTC |
Pritchard Marc S.Chief Brand Officer
|
SaleCommon Stock | 4,030 | $143.79 | $579,473.70 |
DisclosureSEC source: 0000080424-26-000146 · form4.xml · nonDerivative · entry 1 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,000.55 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 16:41 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
SaleCommon Stock | 2,238 | $143.79 | $321,802.02 |
DisclosureSEC source: 0000080424-26-000147 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,988.9685 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 19:04 UTC |
Gama PaulCEO- Health Care
|
SaleCommon Stock | 3,396 | $143.79 | $488,310.84 |
DisclosureSEC source: 0000080424-26-000148 · form4.xml · nonDerivative · entry 1 Gama Paul · CIK 0002110932 · CEO- Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,831.8803 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 19:36 UTC |
Jejurikar ShaileshDirector · Chairman, President and CEO
|
SaleCommon Stock | 6,176 | $143.79 | $888,047.04 |
DisclosureSEC source: 0000080424-26-000149 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,325.9973 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 19:38 UTC |
Purushothaman BalajiChief Human Resources Officer
|
SaleCommon Stock | 2,019 | $143.79 | $290,312.01 |
DisclosureSEC source: 0000080424-26-000150 · form4.xml · nonDerivative · entry 1 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,476.7953 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.